BIOSIGN ANNOUNCES UFIT HEALTH MONITORING STUDY
TORONTO, May 12 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign) announced today the initiation of a short-term study of the UFIT® biomedical system to determine the "best practices" for monitoring blood pressure and blood glucose. The study is being conducted in collaboration with McMaster University, which will use Biosign's technology to benchmark a technology framework for providing reliable and secure health information services.
MORE>>
